Join Us in Advancing Cancer Research from Home.

Funded in part by the National Cancer Institute.

If radiation treatment* is a part of your plan to fight cancer in the abdominal or pelvic area, join RADIANT and contribute to advancing cancer research from home.

*those who are planning, currently undergoing, or have already completed radiation treatment within the last year

Join Us in Advancing Cancer Research from Home.

Funded in part by the National Cancer Institute.

If you are scheduled to start radiation treatment in the abdominal or pelvic area to fight cancer, join RADIANT and contribute to advancing cancer research from home.

Radiation therapy plays an important role in the fight against cancer. Yet, despite its excellent safety profile, about 10% of patients will experience an adverse reaction to the therapy and some patients may not benefit from the therapy at all. The researchers behind the RADIANT study are developing a blood test to help doctors predict a patient’s response to radiation treatment.

Around the country, people whose treatment plan involves radiation therapy to fight cancer in the abdominal or pelvic area are joining RADIANT to help advance cancer research from home.

Advance Cancer Research in 3 Easy Steps

Read and complete the consent form

Complete a DxCollect* fingerstick kit

Let us know how your treatment

Do You Qualify?

  • Do you have access to a computer, tablet, or smartphone?
  • Are you able to use our fingerstick kit to collect a few drops of blood from home?
  • Are you about to start radiation therapy?
  • Have you been diagnosed with one of the following types of cancer?
  • Anal
  • Bladder
  • Cervical
  • Colorectal
  • Esophageal
  • Gallbladder
  • Liver
  • Ovarian
  • Pancreatic
  • Prostate
  • Rectal
  • Renal/Kidney
  • Stomach
  • Testicular
  • Uterine

Advance Cancer Research With Us

*DxCollect fingerstick kit is for Research Use Only. Not for use in diagnostic procedures.

This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSB261201600051C